As patient interest rises for using the antiparasitic drug in cancer, it's having an impact on R&D in the space.
When one of Oregon’s most famous doctors opened a link that a colleague sent him this spring, he expected the usual: a clip from a conference talk or a news segment about the breakthrough leukemia ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results